Sandu Pharmaceuticals Limited (BOM:524703)

India · Delayed Price · Currency is INR

36.72

-0.27 (-0.73%)

At close: Nov 6, 2026

Sandu Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	696.24	699.35	671.92	672.81	653.49	655.01
Revenue Growth	4.16%	4.08%	-0.13%	2.96%	-0.23%	11.48%
Gross Profit	403.46	363.1	329.57	326.41	320.66	276.7
Operating Income	23.49	23.23	20.92	17.12	19.69	23.44
Net Income	17.71	17.66	15.49	14.61	15.21	15.89
Earnings Per Share	2.02	1.83	1.60	1.51	1.61	1.87
EPS Growth	21.50%	14.26%	5.96%	-6.21%	-13.90%	21.43%

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	68.56	68.56	26.53	12.06	22.96	41.71
Total Debt	4.19	4.19	4.78	0.63	-	-
Net Cash (Debt)	64.37	64.37	21.76	11.43	22.96	41.71
Net Cash Growth	195.87%	195.87%	90.33%	-50.21%	-44.96%	-64.16%
Net Cash Per Share	7.34	6.66	2.25	1.18	2.43	4.91

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	61.16	9.5	7.6	2.21	9.49
Capital Expenditures	-	-7.2	-9.38	-14.25	-10.69	-8.41
Free Cash Flow	-	53.96	0.12	-6.65	-8.48	1.08
Free Cash Flow Growth	-	43412.10%	-	-	-	-98.56%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	57.95%	51.92%	49.05%	48.51%	49.07%	42.24%
Operating Margin	3.37%	3.32%	3.11%	2.54%	3.01%	3.58%
Pretax Margin	3.85%	3.80%	3.21%	3.08%	3.39%	3.54%
Profit Margin	2.54%	2.53%	2.31%	2.17%	2.33%	2.43%
FCF Margin	-	7.71%	0.02%	-0.99%	-1.30%	0.16%

Dividends

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 7, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Dividend Per Share	1.000	1.000	0.800	0.800	0.750	0.750
Dividend Per Share Growth	25.00%	25.00%	0%	6.67%	0%	50.00%
Dividend Yield	2.72%	3.28%	1.63%	1.39%	1.22%	1.07%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 7, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	18.17	16.69	30.56	37.94	39.01	39.00
P/FCF Ratio	6.57	5.47	3816.87	-	-	575.52
PS Ratio	0.51	0.42	0.70	0.82	0.91	0.95